Gyre Therapeutics, Inc.GYRENASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P29
Within normal range
vs 5Y Ago
-1.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-59.79%
2024109.93%
2023-4784.39%
2022101.05%
20212.05%
202033.56%
2019-64.55%
201857.46%
201771.05%
201656.47%